Lunit AI solution for PD-L1 expression analysis receives CE mark
Lunit to focus on launching 'Lunit SCOPE PD-L1' in Europe within the second half of 2022
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Apr 22
Lunit to focus on launching 'Lunit SCOPE PD-L1' in Europe within the second half of 2022
28 Apr 22
New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions
27 Apr 22
Impella BTR is a forward flow heart pump designed to be implanted through the axillary artery and placed…
27 Apr 22
The investment will enable Zymo Research’s nucleic acid purification and assay technologies to be integrated with Star Array’s…
27 Apr 22
The clinical trial will assess the safety and technical performance of the ECGenius System and benchmark electrogram signal…
27 Apr 22
The system enables doctors to perform sonography without manually controlling equipment
27 Apr 22
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust…
27 Apr 22
Versi™PD will begin a limited rollout in 2022 with more widespread availability planned in 2023 and beyond.
26 Apr 22
Calcaneal Fracture Plating System and IM Fibula Implant solutions have been approved by the US Food and Drug…
26 Apr 22
The new BD Horizon RealYellow 586 Reagents, developed with dye technology and AI guidance, are capable to boost…